Our research mainly assessed the heterogeneity of tumor-infiltrating immune cells in OV TME and found that three immune checkpoint genes CD274, CTLA-4, and PDCD1LG2, showed negative correlations with risk scores. Here, CTLA4 is linked to neoplasm.